← Back

Chambers Life Sciences & Pharma IP 2026 Global Practice Guide

February 19, 2026
Client Alert, News

We are pleased to have written the chapter on U.S. litigation for the Chambers Life Sciences & Pharma IP 2026 Global Practice Guide. This guide explores the current landscape of patent litigation, including biosimilar and generic market entry, patent term extensions, and available legal remedies.

You can find our chapter here and the entire Global Practice Guide here.

Table of Contents

  • Life Sciences and Pharma/Biopharma Patent Litigation
  • Generic Market Entry
  • Biosimilar Market Entry
  • Patent Term Extensions for Pharmaceutical Products
  • Relief Available for Patent Infringement
  • Other IP Rights
  • Appeal
  • Other Relevant Forums/Procedures
  • Alternative Dispute Resolution
  • Settlement/Antitrust
  • Collective Redress

Authors

Robert Cerwinski

Managing Partner

Profile Page

Michael Johnson

Partner

Profile Page

Heather M. Schneider

Partner

Profile Page

Michael Cottler

Partner

Profile Page

Assistant Author

Sanaea Contractor

Junior Associate (Admission Pending)

Profile Page

Contact

Please reach out to info@geminilaw.com with any questions or feedback.